Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Ottawa Marriott Hotel

Oct 30, 2018 7:00 AM - Oct 31, 2018 3:00 PM

100 Kent Street , Ottawa, ON K1P5R7 , CANADA

DIA Annual Canadian Meeting

Transformation with Collaboration

Session 6: Track B: Emerging Technologies and Therapies

Session Chair(s)

Fiona M Frappier, PhD

Fiona M Frappier, PhD

Senior Policy Analyst

Health Canada, Canada

Emerging technologies have started to disrupt whole industries and in doing so are demonstrating their role as amplifiers for solutions in health outcomes. This session will describe lessons learned in bringing novel therapies through to market. Strategic elements of technology transfer, securing intellectual property, and financing in the Canadian context will focus on overcoming the first valley of death. Key enablers and thought leaders will provide examples of emerging technology companies and spin offs they have shepherded through critical steps.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Describe key considerations in early-stage biotech investing
  • Identify a range of Canadian small start ups
  • List an overview of lessons learned from Canadian case studies


Siofradh  McMahon, MSc

Collaborating to Get Through the Valley(s) of Death in Regenerative Medicine

Siofradh McMahon, MSc

CCRM, Canada

Senior Manager, Clinical Translation and Regulatory affairs

Maxwell  Morgan, JD, LLM

Open Science Opportunities for Development and Commercialization of Novel Therapies

Maxwell Morgan, JD, LLM

Structural Genomics Consortium (SGC), Canada

Lead Legal & Policy Advisor

Nadine  Kolas

Regulation of Advanced Cell Therapies for Regenerative Medicine

Nadine Kolas

Health Canada, Canada

Senior Policy Analyst

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.